Hypophysitis due to IgG4-related disease responding to treatment with azathioprine: An alternative to corticosteroid therapy

Pituitary

Volumn 17, Issue 3, 2014, Pages 251-256

  Caputo, Carmela ^a   Bazargan, Ali ^a   McKelvie, Penelope A ^a   Sutherland, Tom ^a   Su, Charles S ^b   Inder, Warrick J ^c,d  

^a ST VINCENT S HOSPITAL   (Australia)

^b ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Corticosteroid treatment; IgG4 related disease; IgG4 related hypophysitis; Lymphocytic hypophysitis

Indexed keywords

AZATHIOPRINE; DESMOPRESSIN; GROWTH HORMONE; HYDROCORTISONE; PREDNISONE; TESTOSTERONE; THYROID HORMONE; ANTINEOPLASTIC ANTIMETABOLITE; CORTICOSTEROID; IMMUNOGLOBULIN G;

ACINAR ATROPHY; ADULT; ARTICLE; ATROPHY; CASE REPORT; CLINICAL FEATURE; DIABETES INSIPIDUS; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG RESPONSE; EYE INFLAMMATION; EYE PARAESTHESIA; HORMONE SUBSTITUTION; HUMAN; HYPOPHYSIS TUMOR; HYPOPHYSITIS; HYPOPITUITARISM; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN G4 RELATED DISEASE; LACRIMAL GLAND DISEASE; LETHARGY; LYMPHOCYTIC INFILTRATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCULAR FIBROSIS; PARESTHESIA; POLYDIPSIA; POLYURIA; PRIORITY JOURNAL; TREATMENT DURATION; GENETICS; HYPOPHYSIS; LACRIMAL APPARATUS; PATHOLOGY; PITUITARY DISEASES;

ADRENAL CORTEX HORMONES; ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; AZATHIOPRINE; HUMANS; IMMUNOGLOBULIN G; LACRIMAL APPARATUS; MALE; PITUITARY DISEASES; PITUITARY GLAND;

EID: 84905692237     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-013-0498-9     Document Type: Article

References (29)

1. Stone JH, Khosroshahi A, Deshpande V, Chan JK, Heathcote JG, Aalberse R et al (2012) Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthr Rheum 64(10):3061-3067
2. Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T et al (2012) A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol 22(1):1-14
3. Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25(9):1181-1192
4. Ryu JH, Horie R, Sekiguchi H, Peikert T, Yi ES (2012) Spectrum of disorders associated with elevated serum IgG4 levels encountered in clinical practice. Int J Rheumatol 2012:232960
5. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T et al (2001) High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344(10):732-738 (Pubitemid 32204991)
6. Kamisawa T, Egawa N, Nakajima H (2003) Autoimmune pancreatitis is a systemic autoimmune disease. Am J Gastroenterol 98(12):2811-2812
7. van der Vliet HJ, Perenboom RM (2004) Multiple pseudotumor in IgG4-associated multifocal systemic fibrosis. Ann Intern Med 141(11):896-897
8. Yamamoto M, Takahashi H, Ohara M, Suzuki C, Naishiro Y, Yamamoto H et al (2006) A case of Mikulicz's disease (IgG4-related plasmacytic disease) complicated by autoimmune hypophysitis. Scand J Rheumatol 35(5):410-411 (Pubitemid 44601080)
9. Tanabe T, Tsushima K, Yasuo M, Urushihata K, Hanaoka M, Koizumi T et al (2006) IgG4-associated multifocal systemic fibrosis complicating sclerosing sialadenitis, hypophysitis, and retroperitoneal fibrosis, but lacking pancreatic involvement. Intern Med 45(21):1243-1247 (Pubitemid 44848861)
10. Ralli S, Lin J, Farrell J (2007) Autoimmune pancreatitis. N Engl J Med 356(15):1586; author reply 7
11. Wong S, Lam WY, Wong WK, Lee KC (2007) Hypophysitis presented as inflammatory pseudotumor in immunoglobulin G4-related systemic disease. Hum Pathol 38(11):1720-1723 (Pubitemid 47589097)
12. Isaka Y, Yoshioka K, Nishio M, Yamagami K, Konishi Y, Inoue T et al (2008) A case of IgG4-related multifocal fibrosclerosis complicated by central diabetes insipidus. Endocr J 55(4):723-728
13. Tsuboi H, Inokuma S, Setoguchi K, Shuji S, Hagino N, Tanaka Y et al (2008) Inflammatory pseudotumors in multiple organs associated with elevated serum IgG4 level: recovery by only a small replacement dose of steroid. Intern Med 47(12):1139-1142
14. Osawa S, Ogawa Y, Watanabe M, Tominaga T (2009) Hypophysitis presenting with atypical rapid deterioration: with special reference to immunoglobulin G4-related disease-case report. Neurol Med Chir (Tokyo) 49(12):622-625
15. Hori M, Makita N, Andoh T, Takiyama H, Yajima Y, Sakatani T et al (2010) Long-term clinical course of IgG4-related systemic disease accompanied by hypophysitis. Endocr J 57(6):485-492
16. Haraguchi A, Era A, Yasui J, Ando T, Ueki I, Horie I et al (2010) Putative IgG4-related pituitary disease with hypopituitarism and/or diabetes insipidus accompanied with elevated serum levels of IgG4. Endocr J 57(8):719-725
17. Leporati P, Landek-Salgado MA, Lupi I, Chiovato L, Caturegli P (2011) IgG4-related hypophysitis: a new addition to the hypophysitis spectrum. J Clin Endocrinol Metab 96(7):1971-1980
18. Patel SM, Szostek JH (2011) IgG4-related systemic disease in a Native American man. Intern Med 50(8):931-934
19. Hsing MT, Hsu HT, Cheng CY, Chen CM (2013) IgG4-related hypophysitis presenting as a pituitary adenoma with systemic disease. Asian J Surg 36(2):93-97
20. Hattori Y, Tahara S, Ishii Y, Kitamura T, Inomoto C, Osamura RY, et al (2013) A case of IgG4-related hypophysitis without pituitary insufficiency. J Clin Endocrinol Metab 98(5):1808-1811
21. Masaki Y, Kurose N, Yamamoto M, Takahashi H, Saeki T, Azumi A et al (2012) Cutoff values of serum IgG4 and histopathological IgG4+ plasma cells for diagnosis of patients with IgG4-related disease. Int J Rheumatol 2012:580814
22. Bosco JJ, Suan D, Varikatt W, Lin MW (2013) Extra-pancreatic manifestations of IgG4-related systemic disease: a single-centre experience of treatment with combined immunosuppression. Intern Med J 43(4):417-423
23. Khosroshahi A, Carruthers MN, Deshpande V, Unizony S, Bloch DB, Stone JH (2012) Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore) 91(1):57-66
24. Wong PC, Fung AT, Gerrie AS, Moloney G, Maberley D, Rossman D et al (2013) IgG4-related disease with hypergammaglobulinemic hyperviscosity and retinopathy. Eur J Haematol 90(3):250-256
25. Gutenberg A, Hans V, Puchner MJ, Kreutzer J, Bruck W, Caturegli P et al (2006) Primary hypophysitis: clinical-pathological correlations. Eur J Endocrinol 155(1):101-107 (Pubitemid 44103378)
26. Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR (2005) Autoimmune hypophysitis. Endocr Rev 26(5):599-614 (Pubitemid 41127273)
27. Caturegli P, Lupi I, Landek-Salgado M, Kimura H, Rose NR (2008) Pituitary autoimmunity: 30 years later. Autoimmun Rev 7(8):631-637
28. Kamisawa T, Okazaki K, Kawa S, Shimosegawa T, Tanaka M (2010) Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol 45(5):471-477
29. Church NI, Pereira SP, Deheragoda MG, Sandanayake N, Amin Z, Lees WR et al (2007) Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series. Am J Gastroenterol 102(11):2417-2425 (Pubitemid 47631797)